 | • レポートコード：MRC2Q12-19137 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、インスリンアスパルトのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 インスリンアスパルトのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 インスリンアスパルトの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 インスリンアスパルトのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのインスリンアスパルトの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のインスリンアスパルトの売上および2028年までの予測に焦点を当てています。 インスリンアスパルトのグローバル主要企業には、Toho Pharmaceutical、Hisun Pharmaceutical、Federal Pharmaceuticals、Ganlee Pharmaceuticals、Novo Nordisk、Sanofiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 インスリンアスパルト市場は、タイプとアプリケーションによって区分されます。世界のインスリンアスパルト市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 3Ml:300ユニット、10Ml:1000ユニット 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - インスリンアスパルト製品概要 - タイプ別市場（3Ml:300ユニット、10Ml:1000ユニット） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のインスリンアスパルト販売量予測2017-2028 - 世界のインスリンアスパルト売上予測2017-2028 - インスリンアスパルトの地域別販売量 - インスリンアスパルトの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別インスリンアスパルト販売量 - 主要メーカー別インスリンアスパルト売上 - 主要メーカー別インスリンアスパルト価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（3Ml:300ユニット、10Ml:1000ユニット） - インスリンアスパルトのタイプ別販売量 - インスリンアスパルトのタイプ別売上 - インスリンアスパルトのタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - インスリンアスパルトのアプリケーション別販売量 - インスリンアスパルトのアプリケーション別売上 - インスリンアスパルトのアプリケーション別価格 ・北米市場 - 北米のインスリンアスパルト市場規模（タイプ別、アプリケーション別） - 主要国別のインスリンアスパルト市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのインスリンアスパルト市場規模（タイプ別、アプリケーション別） - 主要国別のインスリンアスパルト市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のインスリンアスパルト市場規模（タイプ別、アプリケーション別） - 主要国別のインスリンアスパルト市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のインスリンアスパルト市場規模（タイプ別、アプリケーション別） - 主要国別のインスリンアスパルト市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのインスリンアスパルト市場規模（タイプ別、アプリケーション別） - 主要国別のインスリンアスパルト市場規模（トルコ、サウジアラビア） ・企業情報 Toho Pharmaceutical、Hisun Pharmaceutical、Federal Pharmaceuticals、Ganlee Pharmaceuticals、Novo Nordisk、Sanofi ・産業チェーン及び販売チャネル分析 - インスリンアスパルトの産業チェーン分析 - インスリンアスパルトの原材料 - インスリンアスパルトの生産プロセス - インスリンアスパルトの販売及びマーケティング - インスリンアスパルトの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - インスリンアスパルトの産業動向 - インスリンアスパルトのマーケットドライバー - インスリンアスパルトの課題 - インスリンアスパルトの阻害要因 ・主な調査結果 |
It is a modified type of medical insulin used to treat type 1 and type 2 diabetes
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Insulin Aspart is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Insulin Aspart is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Insulin Aspart is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Insulin Aspart include Toho Pharmaceutical, Hisun Pharmaceutical, Federal Pharmaceuticals, Ganlee Pharmaceuticals, Novo Nordisk and Sanofi, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Insulin Aspart manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Insulin Aspart market. Further, it explains the major drivers and regional dynamics of the global Insulin Aspart market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Toho Pharmaceutical
Hisun Pharmaceutical
Federal Pharmaceuticals
Ganlee Pharmaceuticals
Novo Nordisk
Sanofi
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by specification and by application segments based on sales, price, and value for the period 2017-2028.
Insulin Aspart Segment by Specification
3Ml: 300 Units
10Ml: 1000 Units
Insulin Aspart Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Insulin Aspart market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Insulin Aspart, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Insulin Aspart, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Insulin Aspart, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Insulin Aspart sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Insulin Aspart market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Insulin Aspart sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Toho Pharmaceutical, Hisun Pharmaceutical, Federal Pharmaceuticals, Ganlee Pharmaceuticals, Novo Nordisk and Sanofi, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Insulin Aspart in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Insulin Aspart manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by specification, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by specification, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by specification, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by specification, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by specification, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Aspart sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Insulin Aspart Product Introduction
1.2 Market by Specification
1.2.1 Global Insulin Aspart Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 3Ml: 300 Units
1.2.3 10Ml: 1000 Units
1.3 Market by Application
1.3.1 Global Insulin Aspart Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Aspart Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Aspart Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Aspart Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Aspart Sales by Region
2.4.1 Global Insulin Aspart Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Aspart by Region (2023-2028)
2.5 Global Insulin Aspart Revenue by Region
2.5.1 Global Insulin Aspart Revenue by Region (2017-2022)
2.5.2 Global Insulin Aspart Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Aspart Sales by Manufacturers
3.1.1 Global Top Insulin Aspart Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Aspart Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Aspart in 2021
3.2 Global Insulin Aspart Revenue by Manufacturers
3.2.1 Global Insulin Aspart Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Aspart Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Aspart Revenue in 2021
3.3 Global Insulin Aspart Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Aspart Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Aspart Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Insulin Aspart Sales by Specification
4.1.1 Global Insulin Aspart Historical Sales by Specification (2017-2022)
4.1.2 Global Insulin Aspart Forecasted Sales by Specification (2023-2028)
4.1.3 Global Insulin Aspart Sales Market Share by Specification (2017-2028)
4.2 Global Insulin Aspart Revenue by Specification
4.2.1 Global Insulin Aspart Historical Revenue by Specification (2017-2022)
4.2.2 Global Insulin Aspart Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Insulin Aspart Revenue Market Share by Specification (2017-2028)
4.3 Global Insulin Aspart Price by Specification
4.3.1 Global Insulin Aspart Price by Specification (2017-2022)
4.3.2 Global Insulin Aspart Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Insulin Aspart Sales by Application
5.1.1 Global Insulin Aspart Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Aspart Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Aspart Sales Market Share by Application (2017-2028)
5.2 Global Insulin Aspart Revenue by Application
5.2.1 Global Insulin Aspart Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Aspart Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Aspart Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Aspart Price by Application
5.3.1 Global Insulin Aspart Price by Application (2017-2022)
5.3.2 Global Insulin Aspart Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Aspart Market Size by Specification
6.1.1 North America Insulin Aspart Sales by Specification (2017-2028)
6.1.2 North America Insulin Aspart Revenue by Specification (2017-2028)
6.2 North America Insulin Aspart Market Size by Application
6.2.1 North America Insulin Aspart Sales by Application (2017-2028)
6.2.2 North America Insulin Aspart Revenue by Application (2017-2028)
6.3 North America Insulin Aspart Market Size by Country
6.3.1 North America Insulin Aspart Sales by Country (2017-2028)
6.3.2 North America Insulin Aspart Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Insulin Aspart Market Size by Specification
7.1.1 Europe Insulin Aspart Sales by Specification (2017-2028)
7.1.2 Europe Insulin Aspart Revenue by Specification (2017-2028)
7.2 Europe Insulin Aspart Market Size by Application
7.2.1 Europe Insulin Aspart Sales by Application (2017-2028)
7.2.2 Europe Insulin Aspart Revenue by Application (2017-2028)
7.3 Europe Insulin Aspart Market Size by Country
7.3.1 Europe Insulin Aspart Sales by Country (2017-2028)
7.3.2 Europe Insulin Aspart Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Aspart Market Size by Specification
8.1.1 Asia Pacific Insulin Aspart Sales by Specification (2017-2028)
8.1.2 Asia Pacific Insulin Aspart Revenue by Specification (2017-2028)
8.2 Asia Pacific Insulin Aspart Market Size by Application
8.2.1 Asia Pacific Insulin Aspart Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Aspart Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Aspart Market Size by Region
8.3.1 Asia Pacific Insulin Aspart Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Aspart Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Insulin Aspart Market Size by Specification
9.1.1 Latin America Insulin Aspart Sales by Specification (2017-2028)
9.1.2 Latin America Insulin Aspart Revenue by Specification (2017-2028)
9.2 Latin America Insulin Aspart Market Size by Application
9.2.1 Latin America Insulin Aspart Sales by Application (2017-2028)
9.2.2 Latin America Insulin Aspart Revenue by Application (2017-2028)
9.3 Latin America Insulin Aspart Market Size by Country
9.3.1 Latin America Insulin Aspart Sales by Country (2017-2028)
9.3.2 Latin America Insulin Aspart Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Aspart Market Size by Specification
10.1.1 Middle East and Africa Insulin Aspart Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Insulin Aspart Revenue by Specification (2017-2028)
10.2 Middle East and Africa Insulin Aspart Market Size by Application
10.2.1 Middle East and Africa Insulin Aspart Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Aspart Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Aspart Market Size by Country
10.3.1 Middle East and Africa Insulin Aspart Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Aspart Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Toho Pharmaceutical
11.1.1 Toho Pharmaceutical Corporation Information
11.1.2 Toho Pharmaceutical Overview
11.1.3 Toho Pharmaceutical Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Toho Pharmaceutical Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Toho Pharmaceutical Recent Developments
11.2 Hisun Pharmaceutical
11.2.1 Hisun Pharmaceutical Corporation Information
11.2.2 Hisun Pharmaceutical Overview
11.2.3 Hisun Pharmaceutical Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hisun Pharmaceutical Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hisun Pharmaceutical Recent Developments
11.3 Federal Pharmaceuticals
11.3.1 Federal Pharmaceuticals Corporation Information
11.3.2 Federal Pharmaceuticals Overview
11.3.3 Federal Pharmaceuticals Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Federal Pharmaceuticals Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Federal Pharmaceuticals Recent Developments
11.4 Ganlee Pharmaceuticals
11.4.1 Ganlee Pharmaceuticals Corporation Information
11.4.2 Ganlee Pharmaceuticals Overview
11.4.3 Ganlee Pharmaceuticals Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ganlee Pharmaceuticals Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ganlee Pharmaceuticals Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novo Nordisk Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Aspart Industry Chain Analysis
12.2 Insulin Aspart Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Aspart Production Mode & Process
12.4 Insulin Aspart Sales and Marketing
12.4.1 Insulin Aspart Sales Channels
12.4.2 Insulin Aspart Distributors
12.5 Insulin Aspart Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Aspart Industry Trends
13.2 Insulin Aspart Market Drivers
13.3 Insulin Aspart Market Challenges
13.4 Insulin Aspart Market Restraints
14 Key Findings in The Global Insulin Aspart Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer